Header image for Join Sweden Summit 2025
Profile image for Industry track: Life Sciences

Industry track: Life Sciences Passed

Wednesday February 19, 2025 14:00 - 17:15 Breakout Room 1

Speaker: Emelie Antoni (AstraZeneca)
Moderator: Nina Rawal (Trill Impact)
Panelists: Aida Habtezion (Pfizer Inc.), Anders Persson (AstraZeneca), Boubou Hallberg (Sahlgrenska University Hospital), Britta Stenson (Business Sweden), Carl Bennet (Carl Bennet AB ), Christophe Pedroletti (Karolinska University Hospital), Christopher Jon Stokes (Lilly), Diego Ardigò (Chiesi Farmaceutici spa), Gunilla Andrew-Nielsen (Swedish Medical Products Agency), Gunilla Osswald (BioArctic AB), Janet Hoogstraate (NorthX Biologics AB), Jeppe Theisen (Novo Nordisk), Jessica Martinsson (SwedenBIO), Jörg Schulze (Bristol Myers Squibb), Koki Sato (Takeda), Lorenzo Roversi (IonQ), Nasim Bergman Farrokhnia (Microsoft EMEA (Europe, Middle East, and Africa)), Pascal Roché (RAMSAY SANTE), Reagan Jarvis (Anocca ), Richard Rosenquist Brandell (Karolinska Institutet), Roman Stampfli (Amgen), Stefan Hendriks (Novartis), Therese Lindé (Elekta AB), Thomas Allvin (EFPIA), Yoshito Nakanishi (Roche AB)
Industry track host: Acko Ankarberg Johansson (Government Offices of Sweden)

Type: Industry tracks

Setting the scene

  • Acko Ankarberg Johansson, Minister for Health Care

AstraZeneca as a cornerstone of Swedish Life Science (Kenote)

  •  Emelie Antoni, Nordic and Sweden Country President, AstraZeneca 

The Swedish infrastructure for Precision Medicine – from molecule to patient benefit  (Panel )
Precision medicine is the future of healthcare. Explore how the Swedish innovation- and healthcare system is adapting to future treatments, from diagnosis to treatments.

  • Richard Rosenquist Brandell, Professor Karolinska Institute, Genomic Medicine Sweden
  • Boubou Hallberg, CEO, Sahlgrenska University Hospital  
  • Thomas Allvin, Executive Director Strategy and Board Coordination, EFPIA
  • Roman Stampfli, Regional General Manager, Amgen 

The Swedish springboard for discovery, development and production of advance therapies  (Panel)
Sweden is making significant investments to bridge gaps and facilitate the journey from ideas in cell, gene, and tissue therapy to the first clinical batches. Explore how collaborations among organizations, clusters, and industry players are driving the scale-up of advanced therapy medical products (ATMP). 

  • Janet Hoogstrate, CEO, NorthXBiologics
  • Anders Persson, Head of Ecosystem Strategy & Projects, AZ BIO-Venture Hub 
  • Lorenzo Roversi, Managing Director UK and Nordics, IonQ 

Audience discussions and Q&A
Audience is invited to share remarks and insights with regards to the two previous discussions, after a few selected remarks

  • Jeppe Theisen, CVP,  NovoNordisk
  • Diego Ardigo, Executive Vice President Global Research and Development, Chiesi
  • Stefan Hendriks, Head Western European Cluster Novartis, Novartis

Clinical Trials and Beyond: Sweden's Commitment to Global Life Sciences Research  (Panel)
In the recently updated Life Sciences strategy, Sweden welcomes international collaborations for clinical trials through the launch of a national coordination platform. The Swedish government is announcing substantial investments for research and development in Life Sciences. International partnerships will be significant for enabling these innovation investments to come to life.  

  • Dr. Aida Habtezion, MD, Chief Medical Officer, Pfizer
  • Gunilla Andrew Nielsen, Head of Clinical Trials, Swedish Medical Product Agency 
  • Dr. Christophe Pedroletti, CEO, Karolinska University Hospital 

Digital Healthcare transformation for precision and preventative health (Panel)
Explore how Swedish Healthcare is leading the way, embracing digital technologies to enable patient centric solutions and discuss what the future will bring

  • Pascal Roché, Directeur Général, Ramsay Santé  
  • Nasim Farrokhnia, Industry Director, Healthcare and Life Sciences, Microsoft EMEA
  • Therese Lindé, VP Head of Global Policy & Patient Access, Elekta

Seeds of tomorrow: International collaboration for life sciences innovation (Fireside Chat)
Sweden’s Life Science industry plays a crucial role on the global stage. Through international collaborations and partnerships, Swedish companies contribute to global advancements in healthcare. With a high degree of university spin-outs, Sweden enables the commercialization of innovative healthcare solutions, benefiting patients  worldwide.

Fireside Chat 1

  • Jessica Martinsson, SwedenBIO
  • Reagan Jarvis, CEO, Anocca
  • Carl Bennet, CEO and Chairman, Carl Bennet AB

Fireside Chat 2

  • Thommen Chacko, General Manager Nordics, BMS
  • Gunilla Osswald, CEO, BioArctic

Audience discussions and Q&A
Audience is invited to share remarks and insights with regards to the two previous discussions, after a few selected remarks

  • Koki Sato, General Manager Nordics, Takeda
  • Christopher Stokes, President & GM Northern European Hub, Lilly
  • Yoshito Nakanishi, General Manager, Roche

Concluding Remarks  

  • Acko Ankarberg Johansson, Minister for Health Care 

Lecturers

Profile image for Emelie Antoni

Emelie Antoni Speaker

Nordic and Sweden Country President
AstraZeneca

Profile image for Nina Rawal

Nina Rawal Moderator

Partner and Co-Head, Ventures
Trill Impact

Profile image for Aida Habtezion

Aida Habtezion Panelist

MD, Chief Medical Officer Pfizer
Pfizer Inc.

Profile image for Anders Persson

Anders Persson Panelist

Head of Ecosystem Strategy & Projects
AstraZeneca

Anders is the Head of Ecosystem Strategy and Projects, AstraZeneca in Sweden and is a member of the AstraZeneca Sweden LT. The ecosystem role has a focus on tomorrow's technology and science and to enable a thriving life science scene. Anders has held several project and line management roles in the global AZ R&D organization. After being based in Gaithersburg, Maryland in the USA for a few years, Gothenburg is now his home. In addition to his role within AstraZeneca, Anders is the chairman for the board of SwedenBio (the association for the life science industry in Sweden) and a member of the advisory board for RISE (the Research Institutes of Sweden). Anders has studied biology, chemistry and has a PhD in Biochemistry at Lund University, Sweden.

Profile image for Boubou Hallberg

Boubou Hallberg Panelist

CEO
Sahlgrenska University Hospital

Profile image for Britta Stenson

Britta Stenson PanelistPartnerOrganizer

Head of Life Science
Business Sweden

Profile image for Carl Bennet

Carl Bennet Panelist

CEO & Chairman
Carl Bennet AB

Profile image for Christophe Pedroletti

Christophe Pedroletti Panelist

CEO
Karolinska University Hospital

Christopher Jon Stokes Panelist

President & GM Northern European Hub
Lilly

Diego Ardigò Panelist

Executive Vice President Global Research and Development
Chiesi Farmaceutici spa

Profile image for Gunilla Andrew-Nielsen

Gunilla Andrew-Nielsen PanelistPartner

Head of Clinical Trials
Swedish Medical Products Agency

Profile image for Gunilla Osswald

Gunilla Osswald Panelist

CEO
BioArctic AB

Profile image for Janet Hoogstraate

Janet Hoogstraate Panelist

CEO
NorthX Biologics AB

Janet has her academic background from Leiden University in the Netherlands (PhD in Biopharmaceutical Sciences), has done research at Univ. of Utah and Univ. of Iowa and has an EMBA from Hult International School in London. Her research has focused on transport mechanisms and drug properties from drug delivery and absorption to distribution to the brain. Janet has worked in R&D in AstraZeneca in Neuroscience and Pain.
Janet har started Biovation Park in Södertälje, and proceeded her career at Valneva Sweden in vaccine manufacturing, including establishing a large scale vaccine product manufacturing facility during the pandemic.
Currently as CEO of NorthX Biologics, a CDMO and infrastructure in manufacturing of advanced biologics, she strives to bring innovative therapies to patients.
Janet is a member of the Board of Mireca Medicines GmbH, Alzecure Pharma AB and APL AB, and is the industry chair of the working group of process development and manufacturing in SwedenBio.

Jeppe Theisen Panelist

CVP
Novo Nordisk

Profile image for Jessica Martinsson

Jessica Martinsson Panelist

CEO
SwedenBIO

Jörg Schulze Panelist

General Manager Nordics
Bristol Myers Squibb

Profile image for Koki Sato

Koki Sato Panelist

General Manager Nordics
Takeda

Profile image for Lorenzo Roversi

Lorenzo Roversi Panelist

Managing Director UK and Nordics
IonQ

Lorenzo Roversi is responsible for building the Quantum Economy in the UK and Nordics. Working with governments, research and enterprise to develop and deploy Quantum Computing, Networking and Quantum Applications across industries including Life Sciences, Automotive, Telecommunications, Aerospace and Financial Services

Prior to joining IonQ Lorenzo spent 15 years with IBM where he held leadership positions in Sweden, India and Switzerland. Lorenzo is an engaged board member with several European and North American Medtech and AI companies.

Profile image for Nasim Bergman Farrokhnia

Nasim Bergman Farrokhnia Panelist

Industry Director, Healthcare and Life Sciences
Microsoft EMEA (Europe, Middle East, and Africa)

I’m Medical doctor and affiliated researcher at Karolinska Institute in Sthlm. I serve as the Industry Director, healthcare and life sciences, Microsoft EMEA (Europe, Middle East, and Africa). I am also the chair of eHealth Doctors within the Swedish Medical Association, and the co-founder of www.digitalcareresearch.com

Profile image for Pascal Roché

Pascal Roché Panelist

Directeur Général
RAMSAY SANTE

Profile image for Reagan Jarvis

Reagan Jarvis Panelist

CEO
Anocca

Profile image for Richard Rosenquist Brandell

Richard Rosenquist Brandell Panelist

Professor
Karolinska Institutet

Profile image for Roman Stampfli

Roman Stampfli Panelist

Regional General Manager
Amgen

Profile image for Stefan Hendriks

Stefan Hendriks Panelist

Head Western European Cluster Novartis
Novartis

Profile image for Therese Lindé

Therese Lindé Panelist

VP Head of Global Policy & Patient Access
Elekta AB

Profile image for Thomas Allvin

Thomas Allvin Panelist

Executive Director Strategy and Board Coordination
EFPIA

Profile image for Yoshito Nakanishi

Yoshito Nakanishi Panelist

General Manager
Roche AB

Profile image for Acko Ankarberg Johansson

Acko Ankarberg Johansson Industry track hostPartner

Minister for Health Care
Government Offices of Sweden